Role of cytokines in autologous bone marrow transplantation.

Published

Journal Article (Review)

High-dose chemotherapy with autologous bone marrow support has been increasingly used in the treatment of malignant disease. The use of hematopoietic colony-stimulating factors (CSF), particularly when coupled with the use of CSF-primed peripheral blood progenitor cells, has enabled a substantial reduction in the duration of severe leukopenia and in the morbidity associated with bone marrow transplantation. Furthermore, their use has reduced resource utilization and hospital charges and has also permitted the performance of autologous bone marrow transplantation support largely on an outpatient basis.

Full Text

Duke Authors

Cited Authors

  • Peters, WP; Ross, M; Vredenburgh, J; Hussein, A; Meisenberg, B; Gilbert, C; Petros, WP; Kurtzberg, J

Published Date

  • June 1, 1993

Published In

Volume / Issue

  • 7 / 3

Start / End Page

  • 737 - 747

PubMed ID

  • 8344888

Pubmed Central ID

  • 8344888

International Standard Serial Number (ISSN)

  • 0889-8588

Language

  • eng

Conference Location

  • United States